Table 4.
Association between hsCRP levels at baseline and risk of cancer
| Cancer type | Patients (n %) | hsCRP (mg/L), HR (95% CI)
|
Ptrend | ||
|---|---|---|---|---|---|
| <1 | 1–3 | >3 | |||
| Any cancera | 322 (1.66) | 1 | 1.14 (0.86–1.52) | 1.62 (1.23–2.14) | 0.001 |
| Breast cancerb | 87 (0.45) | 1 | 1.25 (0.73–2.15) | 1.74 (1.01–2.97) | 0.047 |
| Lung cancera | 38 (0.20) | 1 | 1.00 (0.45–2.25) | 1.33 (0.60–2.96) | 0.525 |
| Colorectal cancera | 31 (0.16) | 1 | 1.07 (0.45–2.57) | 0.87 (0.32–2.36) | 0.880 |
| Other cancersa | 166 (0.85) | 1 | 1.13 (0.76–1.69) | 1.80 (1.23–2.64) | 0.004 |
a
Adjusted for age, smoking, drinking, BMI, diabetes, and physical activity.
b
Adjusted for age, smoking, drinking, BMI, diabetes, physical activity, and marital status.